RNA therapeutics face key delivery challenges including instability, targeting limits, and scale-up variability. Advances in lipid nanoparticles, micelles, and integrated platforms—such as those developed by Creative Biolabs—are improving translational success.   Lipid-based drug delivery systems are central to modern RNA therapeutics, gene editing technologies, and...